WEBSITECHANGES

Website Changes

---

03/12/2026

Musella Foundation Copayment Assistance Program Now Closed

---

03/02/2026

$434,000 Awarded for Brain Tumor Research in 2026

---

03/02/2026

Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma in British Columbia

---

03/02/2026

Advanced Brain Cancer Survival Rates Double with LITT

---

03/02/2026

Musella Foundation Copay Program Closing Soon

---

03/02/2026

Webinar tomorrow!

---

03/02/2026

FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases

---

03/02/2026

Tumor-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis

---

02/23/2026

Webinar next week

---

02/23/2026

Curtana Pharmaceuticals` CT-179 Overcomes Immunotherapy Resistance in Glioblastoma

---

02/16/2026

FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer

---

02/16/2026

‘Incredibly excited’: Richard Scolyer hails new US trial for brain cancer

---

02/16/2026

Musella Foundation Awards Multiple Research Grants

---

02/16/2026

Upcoming webinar!

---

02/16/2026

New Molecule Blocks Deadliest Brain Cancer at Its Genetic Root

---

02/09/2026

College scholarship opportunity for NY/NJ/CT pediatric brain tumor survivors

---

02/09/2026

Artwork needed!

---

02/09/2026

NCCN commemorates World Cancer Day with new commitment to update patient resources

---

02/09/2026

Itaconate identified as a new target for pediatric brain tumors called ependymomas

---

02/09/2026

Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial

---

02/02/2026

New Publication Highlights GB13 as a Promising Therapeutic Strategy for DIPG

---

02/02/2026

Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma

---

02/02/2026

Copayment assistance program now open!

---

01/26/2026

Meningiomas Slowed By Targeted Therapy, Shows NCI Clinical Trials Network Group

---

01/26/2026

Artwork Needed!

---